NovoEight IV 3000, manufactured by Novo Nordisk Pharma, contains turoctocog alpha (genetically recombination), a recombinant human coagulation factor VIII for the treatment and prophylaxis of bleeding in hemophilia A. It is supplied as 3,000 IU x 1 bottle with dissolving liquid (YJ code: 6343440D6025).
NovoEight IV 3000
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →